Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Maternal Serum Stathmin-1 Levels as a Biomarker in Preeclampsia and Severe Preeclampsia

NCT06481683 is registered in ClinicalTrials.gov with Burak Yücel Special Clinic as lead sponsor.

NCT NCT06481683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06481683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Maternal Serum Stathmin-1 Levels as a Biomarker in Preeclampsia and Severe Preeclampsia
Lead sponsor
Burak Yücel Special Clinic
Phase
Observational
Overall status
Terminated
Start date
January 1, 2023
Completion date
August 15, 2023
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

preeclampsia